The Clinical Analysis of Triamcinolone Acetonide for Cystoid Macular Edema in Diabetic

Objective To investigate the triamcinolone acetonide for diabetic macular edema clinical efficacy.Methods August 2011-2013 in January in our hospital 60 cases of cystoid macular edema in patients with diabetes,a total of 84.All patients underwent retrobulbar injection of triamcinolone acetonide in patients after treatment,measurement and evaluation of visual acuity after 1 week of treatment situations;would 1,2,3 months after treatment visual,acuity macular fluorescein leakage area and central macular thickness than before treatment,the incidence of complications in patients with followup.Results 1 week after treatment,visual acuity improved in all patients was 92.86%(78/84);1,2,3 months after treatment macular fluorescein leakage area was significantly reduced or disappeared,visual acuity and central macular thickness were better than before treatment,the difference was significant,with statistical significance(P0.05);All patients were followed three month period,the complication rate was 0.Conclusion Triamcinolone acetonide treatment of diabetic macular edema with better treatment,the advantage of fewer adverse reactions,it is worthy of clinical application.